Pranidipine enhances relaxation produced by endothelium-derived relaxing factor in carotid artery

European Journal of Pharmacology

Volumn 385, Issue 2-3, 1999, Pages 191-197

  Koshita, Makoto ^a   Takano, Hiromichi ^a   Nakahira, Yoko ^a   Suzuki, Hikaru ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Ca2+ channel antagonist; Carotid artery, (guinea pig); cGMP; EDRF (endothelium derived relaxing factor); Relaxation

Indexed keywords

CALCIUM CHANNEL; CYCLIC GMP; ENDOTHELIUM DERIVED RELAXING FACTOR; NITRIC OXIDE; NORADRENALIN; PRANIDIPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; ENDOTHELIUM CELL; GUINEA PIG; NONHUMAN; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0032787546     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00702-5     Document Type: Article

References (22)

1. Bauersachs J., Popp R., Hecker M., Sauer E., Fleming I., Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation. 94:1996;3341-3347.
2. Chen G., Suzuki H. Some electrical properties of the endothelium-dependent hyperpolarization in arterial smooth muscle cells of the rat. J. Physiol. 410:1989;91-106.
3. Chen G., Suzuki H., Weston A.H. Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br. J. Pharmacol. 95:1988;1165-1174.
4. Cocks T.M., Angus J.A. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature. 305:1983;627-630.
5. Furchgott R.F. Role of endothelium in response to vascular smooth muscle. Circ. Res. 53:1983;557-573.
6. Garland C.J., Plane F., Kemp B.K., Cocks T.M. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol. Sci. 16:1995;23-30.
7. Garthwaite J., Southam E., Boulton C.L., Nielsen E.B., Schmidt K., Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1 H-[1,2,4] oxadiazolo [4,3-a] quinoxalin-l-one. Mol. Pharmacol. 48:1995;184-188.
8. Griffith T.M., Edwards D.H., Lewis M.J., Newby A.C., Henderson A.H. Production of endothelium-derived relaxing factor is dependent on oxidative phosphorylation and extracellular calcium. Cardiovasc. Res. 20:1986;7-12.
9. 2+ channel antagonist, in rats: comparison with nifedipine and amlodipine. Eur. J. Pharmacol. 324:1997;201-204.
10. Ibengwe J.K., Suzuki H. Changes in mechanical responses of vascular smooth muscles to acetylcholine, noradrenaline and high-potassium solution in hypercholesterolemic rabbits. Br. J. Pharmacol. 87:1986;395-402.
11. Ignarro L.J., Byrns R.E., Buga G.M., Wood K.S. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacological and chemical properties that are identical to those of nitric oxide radical. Circ. Res. 61:1987;866-879.
12. Itoh T., Seki N., Suzuki S., Ito S., Kajikuri J., Kuriyama H. Membrane hyperpolarization inhibits agonist-induced synthesis of inositol 1,4,5-trisphosphate in rabbit mesenteric artery. J. Physiol. 451:1992;307-328.
13. i in endothelial cells by membrane potential. Rubanyi G.M., Vanhoutte P.M. Endothelium-Derived Relaxing Factors. 1990;128-135 Karger, Barsel.
14. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
15. Mori T., Takeuchi T., Ohura M., Miyakoda G., Fujiki H., Orito K., Yoshida K., Hirano T., Yamaura Y., Sumida T., Nakaya Y., Satake H., Hata F. Pranidipine, a new 1,4- dihydropyridine calcium channel blocker, enhances cyclic GMP-independent nitric oxide-induced relaxation of the rat aorta. Mol. Cell. Biochem. 178:1998;335-343.
16. Nakayama N., Ikezono K., Mori T., Yamashita S., Nakayama S., Tanaka Y., Hosokawa T., Minami Y., Matsutani K., Yamamura Y., Yabuuchi Y. Antihypertensive activity of OPC-13340, a new potent and long-acting dihydropyridine calcium antagonist, in rats. J. Cardiovasc. Pharmacol. 15:1990;836-844.
17. Nakayama N., Ikezono K., Fujio N., Sasabe H., Kitaura K., Tamada S., Shirafuji T., Yabuuchi Y. OPC-13340, a new potent long-acting dihydropyridine calcium antagonist. Cardiovasc. Drug Rev. 9:1991;147-157.
18. Nakayama N., Ikezono K., Ohura M., Yabuuchi Y. Effects of the new long-acting dihydropyridine calcium antagonist pranidipine on the endothelium-dependent relaxation in isolated rat aorta in vitro. Arzneim.-Forsch. 43:1993;1266-1270.
19. Nelson M.T., Patlak J.B., Worley J.F., Standen N.B. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am. J. Physiol. 259:1990;C3-C18.
20. Suzuki H., Chen G. Endothelium-derived hyperpolarizing factor (EDHF): an endogenous potassium-channel activator. News Physiol. Sci. 5:1990;212-215.
21. Suzuki H., Chen G., Yamamoto Y., Miwa K. Nitroarginine-sensitive and insensitive components of the endothelium-dependent relaxation in the guinea-pig carotid artery. Jpn. J. Physiol. 42:1992;335-347.
22. Zhang G., Yamamoto Y., Miwa K., Suzuki H. Vasodilation induced by substance P in the guinea-pig carotid artery. Am. J. Physiol. 266:1994;H1132-H1137.